Showing results (721-730 of 2,503) with videos related to
Sort By:
Pageof 251
Journal of Diabetes Investigation|December 27, 2022
Promoting pancreatic β cell proliferation: A powerful key for realizing regenerative therapy for diabetesYukihiro Shimaya, Nobuaki Shiraki, Shoen KumeJournal of Diabetes Investigation|December 23, 2022
Insulin allergy manifesting soon after COVID-19 vaccination (BNT162b2)Hiroshi Komamura, Yohei Kawana, Junta Imai, et al.Journal of Diabetes Investigation|December 13, 2022
Influence of hepatitis B virus on the prevalence of diabetes complications in patients with type 2 diabetesXi-Yu Liu, Yan ZhouJournal of Diabetes Investigation|November 14, 2019
Association between gut microbiota composition and glycoalbumin level during pregnancy in Japanese women: Pilot study from Chiba Study of Mother and Child HealthKenichi Sakurai, Tamotsu Kato, Hiromi Tanabe, et al.Journal of Diabetes Investigation|July 10, 2021
Application of weighted gene co-expression network analysis to identify novel key genes in diabetic nephropathyZheng Wang, Xiaolei Chen, Chao Li, et al.Journal of Diabetes Investigation|June 18, 2021
Frequent scanning using flash glucose monitoring contributes to better glycemic control in children and adolescents with type 1 diabetesTatsuhiko Urakami, Kei Yoshida, Remi Kuwabara, et al.Journal of Diabetes Investigation|December 21, 2020
Incidence of adverse cardiovascular events in type 2 diabetes mellitus patients after initiation of glucose-lowering agents: A population-based community study from the Shizuoka Kokuho databaseShun Kohsaka, Hiraku Kumamaru, Shiori Nishimura, et al.Journal of Diabetes Investigation|July 30, 2021
Appropriate definition of diabetes using an administrative database: A cross-sectional cohort validation studyYuichi Nishioka, Saki Takeshita, Shinichiro Kubo, et al.Journal of Diabetes Investigation|April 4, 2013
Diabetic cardiac autonomic neuropathy, inflammation and cardiovascular diseaseAaron I Vinik, Tomris Erbas, Carolina M CaselliniJournal of Diabetes Investigation|April 30, 2019
Long-term safety and efficacy of the sodium-glucose cotransporter 2 inhibitor, tofogliflozin, added on glucagon-like peptide-1 receptor agonist in Japanese patients with type 2 diabetes mellitus: A 52-week open-label, multicenter, post-marketing clinical studyYasuo Terauchi, Hisataka Fujiwara, Yuji Kurihara, et al.Pageof 251